Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events
Open Access
- 2 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (5) , e018565
Abstract
Background: Patients with transposition of the great arteries corrected by an atrial switch operation experience major clinical events during adulthood, mainly heart failure (HF) and arrhythmias, but data on the emerging risks remain scarce. We assessed the risk for events during the clinical course in adulthood, and provided a novel risk score for event‐free survival. Methods and Results: This multicenter study observed 167 patients with transposition of the great arteries corrected by an atrial switch operation (61% Mustard procedure; age, 28 [interquartile range, 24–36] years) for 13 (interquartile range, 9–16) years, during which 16 (10%) patients died, 33 (20%) had HF events, defined as HF hospitalizations, heart transplantation, ventricular assist device implantation, or HF‐related death, and 15 (9%) had symptomatic ventricular arrhythmias. Five‐year risk of mortality, first HF event, and first ventricular arrhythmia increased from 1% each at age 25 years, to 6% (95% CI, 4%–9%), 23% (95% CI, 17%–28%), and 5% (95% CI, 2%–8%), respectively, at age 50 years. Predictors for event‐free survival were examined to construct a prediction model using bootstrapping techniques. A prediction model combining age >30 years, prior ventricular arrhythmia, age >1 year at repair, moderate or greater right ventricular dysfunction, severe tricuspid regurgitation, and mild or greater left ventricular dysfunction discriminated well between patients at low (20%) 5‐year risk (optimism‐corrected C‐statistic, 0.86 [95% CI, 0.82–0.90]). Observed 5‐ and 10‐year event‐free survival rates in low‐risk patients were 100% and 97%, respectively, compared with only 31% and 8%, respectively, in high‐risk patients. Conclusions: The clinical course of patients undergoing atrial switch increasingly consists of major clinical events, especially HF. A novel risk score stratifying patients as low, intermediate, and high risk for event‐free survival provides information on absolute individual risks, which may support decisions for pharmacological and interventional management.Keywords
This publication has 33 references indexed in Scilit:
- The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 yearsEuropean Heart Journal, 2014
- Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: A single-centre experienceInternational Journal of Cardiology, 2013
- Right Ventricular End-Diastolic Volume Combined With Peak Systolic Blood Pressure During Exercise Identifies Patients at Risk for Complications in Adults With a Systemic Right VentricleJACC, 2013
- ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteriesEuropean Heart Journal, 2009
- Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial BafflesCirculation: Arrhythmia and Electrophysiology, 2008
- CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first resultsEuropean Journal of Epidemiology, 2005
- Late outcome of Senning and Mustard procedures for correction of transposition of the great arteriesHeart, 2005
- Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in BelgiumHeart, 2004
- Arrhythmia and Mortality After the Mustard Procedure: A 30-Year Single-Center ExperienceJACC, 1997